Sign in
4

Changes in Ownership

Entrada Therapeutics, Inc. Filed Acc 0001104659-22-095126

Chief Financial Officer sold 4,669 shares at an average $13.78 ($64,362)

  • Chief Financial Officer acquired 1,117 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

WENTWORTH KORY JAMES · Chief Financial Officer

Table I: Non-derivative

4 lines
Date Transaction Shares Price Value Owned after D/I
2022-08-24 Exercise or conversion : show line 1 in the form +1,117 $2.10 $2,346 15,655 D
2022-08-24 Sale : show line 2 in the form −2,817 $13.52 $38,093 12,838 D
2022-08-24 Sale : show line 3 in the form −301 $14.23 $4,282 12,537 D
2022-08-25 Sale : show line 4 in the form −1,551 $14.18 $21,986 10,986 D
Open-market sales · 4,669 sh · avg $13.78 · $64,362

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2022-08-24 Exercise or conversion : show line 5 in the form Stock Option (Right to Buy) −1,117 108,807 D
Loading xslF345X03/tm2224609-1_4seq1.xml…